Company Filing History:
Years Active: 2018
Title: Innovator Spotlight: Pauline McLean Quigley Sheldon
Introduction: Pauline McLean Quigley Sheldon is a remarkable inventor based in Seattle, WA. With a focus on advancing gene therapy and vaccination technologies, she has made significant contributions to the field of biotechnology.
Latest Patents: She holds one patent titled "Methods for purification of recombinant AAV vectors." This patent details innovative methods for purifying recombinant adeno-associated virus (rAAV) vectors, which play a crucial role in gene transfer. The invention ensures that these vectors are substantially free of impurities, including cellular nucleic acids, cellular proteins, helper viruses, and media components, enhancing their efficacy for therapeutic applications.
Career Highlights: Pauline is associated with Genzyme Corporation, a leading biotechnology company known for its pioneering efforts in genetics and biotechnology. Her work at this prestigious institution underscores her commitment to advancing medical treatments and her expertise in vector purification techniques.
Collaborations: Throughout her career, Pauline has collaborated with notable colleagues including Peter S. Gagnon and Gina Nichols. These professional relationships have undoubtedly contributed to her innovative work and the development of her patented technologies.
Conclusion: Pauline McLean Quigley Sheldon exemplifies the role of inventors in shaping the future of biotechnology. Her contributions, especially in the field of gene therapy, illustrate the importance of innovation in overcoming medical challenges and improving patient outcomes.